Cavalletti E - Search Results

1

Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.

Cignarella G, Barlocco D, Pinna GA, Loriga M, Curzu MM, Tofanetti O, Germini M, Cazzulani P, Cavalletti E. Cignarella G, et al. Among authors: cavalletti e. J Med Chem. 1989 Oct;32(10):2277-82. doi: 10.1021/jm00130a009. J Med Chem. 1989. PMID: 2795599

2

Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones.

Pinna GA, Curzu MM, Barlocco D, Cignarella G, Cavalletti E, Germini M, Berger K. Pinna GA, et al. Among authors: cavalletti e. Farmaco Sci. 1988 Jun;43(6):539-49. Farmaco Sci. 1988. PMID: 3208896

3

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.

Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F, Tofanetti O. Zunino F, et al. Among authors: cavalletti e. Chem Biol Interact. 1989;70(1-2):89-101. doi: 10.1016/0009-2797(89)90065-3. Chem Biol Interact. 1989. PMID: 2736678

4

Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.

Cavalletti E, Tofanetti O, Zunino F. Cavalletti E, et al. Cancer Lett. 1986 Jul;32(1):1-6. doi: 10.1016/0304-3835(86)90032-7. Cancer Lett. 1986. PMID: 3091245

5

Opiate receptors and beta-endorphin levels in brain areas of dogs with portal-systemic encephalopathy.

Zeneroli ML, Ventura E, Pinelli G, Casciarri I, Germini M, Cavalletti E, Tofanetti O, Baraldi M. Zeneroli ML, et al. Among authors: cavalletti e. J Hepatol. 1985;1(6):619-27. doi: 10.1016/s0168-8278(85)80005-2. J Hepatol. 1985. PMID: 2997325

6

Protective effect of reduced glutathione against cis-dichlorodiammine platinum (II)-induced nephrotoxicity and lethal toxicity.

Zunino F, Tofanetti O, Besati A, Cavalletti E, Savi G. Zunino F, et al. Among authors: cavalletti e. Tumori. 1983 Apr 30;69(2):105-11. doi: 10.1177/030089168306900204. Tumori. 1983. PMID: 6683012

7

Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent.

Tofanetti O, Cavalletti E, Besati A, Pratesi G, Pezzoni G, Zunino F. Tofanetti O, et al. Among authors: cavalletti e. Cancer Chemother Pharmacol. 1985;14(3):188-93. doi: 10.1007/BF00258114. Cancer Chemother Pharmacol. 1985. PMID: 3995681

8

ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agents.

Cozza G, Bortolato A, Menta E, Cavalletti E, Spinelli S, Moro S. Cozza G, et al. Among authors: cavalletti e. Anticancer Agents Med Chem. 2009 Sep;9(7):778-86. doi: 10.2174/187152009789056930. Anticancer Agents Med Chem. 2009. PMID: 19799530 Review.

9

Efficacy of glutathione for treatment of fascioliasis. An investigation in the experimentally infested rat.

Maffei Facino R, Carini M, Aldini G, Ceserani R, Casciarri I, Cavalletti E, Verderio L. Maffei Facino R, et al. Among authors: cavalletti e. Arzneimittelforschung. 1993 Apr;43(4):455-60. Arzneimittelforschung. 1993. PMID: 8494576

10

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F. Manzotti C, et al. Among authors: cavalletti e. Clin Cancer Res. 2000 Jul;6(7):2626-34. Clin Cancer Res. 2000. PMID: 10914703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters